More Efforts Needed To Make Taiwan A Springboard To China – BioBusiness Asia Conference
This article was originally published in PharmAsia News
Executive Summary
Cooperation is needed between pharma partners in addition to implementation of cross-strait agreements.
You may also be interested in...
China And Taiwan Move Toward Clinical Data Mutual Acceptance, Regulatory Harmonization
China and Taiwan's top health regulators have signed an agreement to harmonize clinical and non-clinical studies toward mutual data acceptance. The deal could open doors for more Taiwanese drugs in the Chinese market, industry experts say
Taiwan Eyes Cross-strait Biotech Cooperation with China
SHANGHAI - Taiwan hopes to strengthen cooperation with mainland China in the development of the biotechnology and medical device industry, according to Taiwan's Vice Minister of Economic Affairs Huang Chuang-chiou
Taiwan, Japan Eye Drug Regulation Streamlining To Curb Costs
Regulators from Japan and Taiwan met in late December to review prospects for convergence and pointed to manufacturing and new drug approvals as areas that were ripe for harmonization agreements.